3D QSAR studies on GSK-3 inhibition by aloisines

被引:17
|
作者
Zeng, M [1 ]
Jiang, YJ [1 ]
Zhang, B [1 ]
Zheng, KW [1 ]
Zhang, N [1 ]
Yu, QS [1 ]
机构
[1] Zhejiang Univ, Key Lab Mol Design & Nutr Engn, Ningbo Inst Technol, Ningbo 315100, Zhejiang Prov, Peoples R China
关键词
3D-QSAR; GSK-3; aloisines;
D O I
10.1016/j.bmcl.2004.10.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
GSK-3 is involved in various physiological processes and its inhibitors have been evaluated as promising drug candidates for a lot of unmet pathologies. In this paper, inhibition of GSK-3 by aloisines is investigated by 3D QSAR studies. Two alignment rules were applied to check the influence of spatial alignment of the compounds. Both the CoMFA and CoMSIA techniques were carried out and ASS procedure was applied for CoMFA to find a satisfactory model. The best QSAR model obtained is a CoMSIA model characterized with r(2) of 0.938 and q(2) of 0.673 including steric, electrostatic and hydrophobic fields, possessing good predicting ability. To get a better understanding of the relationship between chemical structure and biological activity, a complex structure of aloisine with GSK-3 was obtained by superimposing GSK-3 into the known cocrystal structure of aloisine-CDK2, and then factors that affect the inhibition activity were investigated further, combining the QSAR study with the complex structure, the results of which are in good accordance and complementary to each other. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 50 条
  • [21] Molecular Modeling Studies of C-Glycosylfavone Derivatives as GSK-3β Inhibitors Based on QSAR and Docking Analysis
    Abdellah El Aissouq
    Oussama Chedadi
    Rania Kasmi
    Larbi Elmchichi
    Fatima En-nahli
    Amina Goudzal
    Mohammed Bouachrine
    Abdelkrim Ouammou
    Fouad Khalil
    Journal of Solution Chemistry, 2021, 50 : 808 - 822
  • [22] Dendritic cell maturation occurs through the inhibition of GSK-3β
    Alessandrini, Alessandro
    De Haseth, Stephanie
    Fray, Michael
    Miyajima, Masahiro
    Colvin, Robert B.
    Williams, Winfred W.
    Cosimi, A. Benedict
    Benichou, Gilles
    CELLULAR IMMUNOLOGY, 2011, 270 (02) : 114 - 125
  • [23] GSK-3 inhibition overcomes chemoresistance in human breast cancer
    Ugolkov, Andrey
    Gaisina, Irina
    Zhang, Jin-San
    Billadeau, Daniel D.
    White, Kevin
    Kozikowski, Alan
    Jain, Sarika
    Cristofanilli, Massimo
    Giles, Francis
    O'Halloran, Thomas
    Cryns, Vincent L.
    Mazar, Andrew P.
    CANCER LETTERS, 2016, 380 (02) : 384 - 392
  • [24] Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
    Liu, Xiaolei
    Verma, Anurag
    Garcia, Gustavo
    Ramage, Holly
    Myers, Rebecca L.
    Lucas, Anastasia
    Michaelson, Jacob J.
    Coryell, William
    Kumar, Arvind
    Charney, Alexander W.
    Kazanietz, Marcelo G.
    Rader, Daniel J.
    Ritchie, Marylyn D.
    Berrettini, Wade H.
    Schultz, David C.
    Cherry, Sara
    Damoiseaux, Robert
    Arumugaswami, Vaithilingaraja
    Klein, Peter S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (42)
  • [25] Bradykinin prevents reperfusion injury through inhibition of GSK-3β
    Park, SS
    Mueller, RA
    Patterson, C
    Boysen, PG
    Xu, ZL
    CIRCULATION, 2005, 112 (17) : U253 - U253
  • [26] CDK versus GSK-3 inhibition: a purple haze no longer?
    Fischer, PM
    CHEMISTRY & BIOLOGY, 2003, 10 (12): : 1144 - 1146
  • [27] Inhibition of GSK-3 ameliorates the pathogenesis of Huntington?s disease
    Rippin, Ido
    Bonder, Katherina
    Joseph, Shirley
    Sarsor, Ammar
    Vaks, Lilach
    Eldar-Finkelman, Hagit
    NEUROBIOLOGY OF DISEASE, 2021, 154
  • [28] Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3β inhibitors
    Kim, Ki Hwan
    Gaisina, Irina
    Gallier, Franck
    Holzle, Denise
    Blond, Sylvie Y.
    Mesecar, Andrew
    Kozikowski, Alan P.
    JOURNAL OF MOLECULAR MODELING, 2009, 15 (12) : 1463 - 1479
  • [29] QSAR, 3D QSAR and beyond.
    Kubinyi, H
    Sadowski, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U667 - U667
  • [30] GSK-3 inhibition: Achieving moderate efficacy with high selectivity
    Avrahami, Limor
    Licht-Murava, Avital
    Eisenstein, Miriam
    Eldar-Finkelman, Hagit
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (07): : 1410 - 1414